Integrated CMC Solutions for Advanced Therapies

Leverages advanced expression technologies, optimised vectors, and flexible bioprocessing platforms to deliver scalable and cost‑efficient solutions tailored to companion animal biologics. Supports from early development to GMP manufacturing, with customisation for veterinary specific requirements.

Combines molecular engineering, host cell optimisation, expression system development, and process optimisation to address complex protein structures. The IgMax® platform enables production of pentameric IgM at high expression levels, with near‑complete pentamer assembly and excellent purity after downstre...

Integrated development and manufacturing solutions combining molecular engineering, vector optimization, host cell engineering, and customized process development. The platform delivers high titers for mAb production, and DTEasy™ strategies have demonstrated significant yield improvements across various di...

End‑to‑end biosimilar development from cell line construction to PPQ and commercial batches. The integrated platform enables a fast development timeline, supports global GMP requirements, and offers competitive cost of goods. Includes DS/DP manufacturing, analytical testing, quality support, and technology...

Combines advanced expression technologies with optimised vectors, cell culture processes, and downstream purification for high‑productivity and cost‑efficient manufacturing. Multimerisation and nanoparticle platforms enable the design of defined antigen structures in various multimeric forms, supporting ne...